This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Peter Boberg, Sandra Chan, Matt List and Sean May present the Health Care & Pharmaceutical Committee’s quarterly update, summarizing the most important antitrust developments for Q4 2024 and the transition to the new administration.
For more information on this event, click here.
In the article “Is It Fair? The FTC’s Policies and Enforcement Actions on Unfair Methods of Competition Under Section 5,” published by the American Bar...
Previously in a series of policy letters, Federal Trade Commission staff expressed concerns that transparency could lead to coordinated behavior and higher...
CRA is a proud sponsor of the event aiming to shape your competition law strategy in light of the DMCC Act, the CMA’s current vision & enforcement priorities,...
Benno Buehler is a panelist during the session titled “Challenges to FRAND rate setting – negotiation v. litigation.” For more information on this event, click...
